MTN Stock Overview
Milton Essex Spólka Akcyjna engages in the development and sale of medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Milton Essex Spólka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.58 |
| 52 Week High | zł0.95 |
| 52 Week Low | zł0.45 |
| Beta | 0.41 |
| 1 Month Change | -4.92% |
| 3 Month Change | 17.89% |
| 1 Year Change | -31.36% |
| 3 Year Change | -72.18% |
| 5 Year Change | n/a |
| Change since IPO | -63.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| MTN | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -3.3% | -1.2% | 3.5% |
| 1Y | -31.4% | -6.5% | 27.4% |
Return vs Industry: MTN underperformed the Polish Medical Equipment industry which returned -6.4% over the past year.
Return vs Market: MTN underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
| MTN volatility | |
|---|---|
| MTN Average Weekly Movement | 13.8% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: MTN's share price has been volatile over the past 3 months.
Volatility Over Time: MTN's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 5 | Iwona Kaczynska-Stepien | www.miltonessex.eu |
Milton Essex Spólka Akcyjna engages in the development and sale of medical devices. Its products include SkinSENSE, a solution that automate reading of skin allergic tests; FaceCOV, a medical device that allows remote temperature measurement from a distance; and InfraSKIN, a device that allows the assessment of the metabolic rate in the examined nevus - increased metabolism in the skin nevus indicates pathological cells, addressed to specialist dermatologists and oncologists. The company was incorporated in 2016 and is based in Warsaw, Poland.
Milton Essex Spólka Akcyjna Fundamentals Summary
| MTN fundamental statistics | |
|---|---|
| Market cap | zł9.00m |
| Earnings (TTM) | -zł617.32k |
| Revenue (TTM) | zł401.66k |
22.4x
P/S Ratio-14.6x
P/E RatioIs MTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MTN income statement (TTM) | |
|---|---|
| Revenue | zł401.66k |
| Cost of Revenue | zł25.21k |
| Gross Profit | zł376.45k |
| Other Expenses | zł993.77k |
| Earnings | -zł617.32k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 93.72% |
| Net Profit Margin | -153.69% |
| Debt/Equity Ratio | 0% |
How did MTN perform over the long term?
See historical performance and comparison